Obesity is a major global health crisis, especially in the United States, but newer weight-loss drugs like Eli Lilly’s (LLY) ...

'But it got worse. The fatigue – the same fatigue I'd ironically gone to the GP for in the first place – got worse. I ...

Mounjaro will be rolled out gradually as officials said a "difficult decision" had to be made in order to "protect other ...

Experts are urging anyone looking to shed a few pounds in the New Year to think twice before buying dangerous weight-loss ...

According to the latest Health Survey for England, 64% of adults were either overweight or obese in 2022 ... ways of delivering this new generation of weight loss medications." ...

Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for ...

People facing long waits for NHS weight loss services could be taking matters into their own hands by buying potentially ...

While appreciating diet and exercise, scientists note that they failed to tide on the obesity pandemic and that GLP-1 RAs ...

For people with obesity or type 2 diabetes, glucagon-like peptide 1 (GLP-1) agonists (including Mounjaro, Wegovy, and Ozempic) have been labeled miracle drugs. But they aren’t miraculous for ...

Higher-income households with at least one user of GLP-1 class of weight loss drugs cut their grocery spending by nearly 9%, ...

The history of weight loss medicines reads like a Greek tragedy. However, the biology behind the new GLP-1 agonists suggests ...